With Competition Rising, Should Investors Give Up On This Top Growth Stock?

Intuitive Surgical (NASDAQ: ISRG) has delivered market-crushing returns over the past two decades, thanks to its leadership in the robotic-assisted surgery (RAS) market. Part of the company's appeal is that its crown jewel has had little competition.However, that may change soon. Recent developments suggest that Intuitive's famous RAS device, the da Vinci system, will finally go head-to-head in the U.S. with another robot device. This might suggest that Intuitive Surgical can no longer produce outsize returns, but there's more to the story.Here's what investors need to know.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool